sodium glutamate has been researched along with Growth Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inoue, F; Kinugasa, A; Matsuo, S; Sawada, T; Ueshima, Y; Yamamoto, T | 1 |
| Pampori, NA; Ram, PA; Shapiro, BH; Waxman, DJ | 1 |
| Groot, K; Halmos, G; Izdebski, J; Kovács, M; Schally, AV | 1 |
3 other study(ies) available for sodium glutamate and Growth Disorders
| Article | Year |
|---|---|
Plasma levels of insulin-like growth factor-I are reduced at one week of age in monosodium L-glutamate-treated mice.
Topics: Age Factors; Animals; Animals, Newborn; Growth Disorders; Hypothalamus; Insulin; Insulin-Like Growth Factor I; Male; Mice; Mice, Inbred ICR; Obesity; Sodium Glutamate; Thyroxine | 1993 |
Irreversible suppression of growth hormone-dependent cytochrome P450 2C11 in adult rats neonatally treated with monosodium glutamate.
Topics: Animals; Animals, Newborn; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Female; Growth Disorders; Growth Hormone; Male; Microsomes, Liver; Mixed Function Oxygenases; Pulsatile Flow; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sex Characteristics; Sodium Glutamate | 1993 |
Chronic administration of a new potent agonist of growth hormone- releasing hormone induces compensatory linear growth in growth hormone-deficient rats: mechanism of action.
Topics: Animals; Body Height; Body Weight; Drug Administration Schedule; Drug Evaluation, Preclinical; Female; Growth Disorders; Growth Hormone; Growth Hormone-Releasing Hormone; Insulin-Like Growth Factor I; Male; Pituitary Gland; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide; Receptors, Pituitary Hormone-Regulating Hormone; Reference Values; Secretory Rate; Sodium Glutamate; Tibia | 1996 |